Lundbeck
HLUN-B.CO
#2789
Rank
ยฃ3.44 B
Marketcap
ยฃ3.59
Share price
-1.37%
Change (1 day)
-5.67%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): ยฃ0.29

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is ยฃ0.27. In 2022 the company made an earnings per share (EPS) of ยฃ0.21 a decrease over its 2021 EPS that were of ยฃ0.46.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.2942.69%
2022ยฃ0.21-55.47%
2021ยฃ0.46-51.83%
2020ยฃ0.96-28.01%
2019ยฃ1.33-44.08%
2018ยฃ2.3851.94%
2017ยฃ1.57126.64%
2016ยฃ0.69-120.84%
2015-ยฃ3.325622.18%
2014-ยฃ0.05794-110.03%
2013ยฃ0.58-28.08%
2012ยฃ0.80-52.1%
2011ยฃ1.68-1.31%
2010ยฃ1.7015.61%
2009ยฃ1.47